To support these findings, elevated levels biomarkers of vascular injury, such as soluble intercellular adhesion molecule 1 (sICAM-1) or vascular cell adhesion molecule 1 (sVCAM-1), and markers of BBB damage, such as S100β, have been described in the plasma of COVID-19 patients [34]. This evidence concerns the gene VCAM1 and COVID-19.